TipRanks on MSN23h
Pfizer halts work on hemophilia gene therapy, Nikkei reportsPfizer (PFE) will end global development and commercialization of Beqvez, a gene therapy for hemophilia, Nikkei learned Thursday, after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback